Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 06, 2021

SELL
$0.61 - $0.97 $25,620 - $40,740
-42,000 Closed
0 $0
Q1 2021

May 10, 2021

SELL
$0.73 - $1.43 $5,840 - $11,440
-8,000 Reduced 16.0%
42,000 $38,000
Q4 2020

Feb 10, 2021

BUY
$0.52 - $0.81 $3,120 - $4,860
6,000 Added 13.64%
50,000 $35,000
Q3 2020

Nov 13, 2020

BUY
$0.72 - $1.61 $31,680 - $70,840
44,000 New
44,000 $32,000

Others Institutions Holding NBY

# of Institutions
1
Shares Held
2.94K
Call Options Held
0
Put Options Held
0

About NovaBay Pharmaceuticals, Inc.


  • Ticker NBY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,988,400
  • Market Cap $46.8M
  • Description
  • NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and Phase...
More about NBY
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.